Cisen Pharmaceutical Co., Ltd. (SHA:603367)

China · Delayed Price · Currency is CNY

17.24

+0.14 (0.82%)

Feb 3, 2026, 3:00 PM CST

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Large Infusion	1.74B
Small Volume Injection	1.20B
Small Volume Injection Growth	-8.02%
Oral Solid Dosage Form	512.54M
Oral Solid Dosage Form Growth	7.07%
Freeze-Dried Powder Injection	166.18M
Freeze-Dried Powder Injection Growth	-10.50%
Ointment	165.73M
Ointment Growth	-12.34%
Drops	133.96M
Drops Growth	-16.08%
Raw Materials Medicine	39.85M
Raw Materials Medicine Growth	7.12%
Flushing Agent	18.07M
Other	10.02M
Other Growth	-68.60%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
China	3.94B
China Growth	-10.94%
Foreign	35.74M
Foreign Growth	11.41%